Implementing injectable opioid agonist treatment: a survey of professionals in the field of opioid use disorders

被引:3
|
作者
Archambault, Leonie [1 ]
Goyer, Marie-Eve [2 ]
Sabetti, Judith [1 ]
Perreault, Michel [1 ,3 ]
机构
[1] Douglas Hosp, Res Ctr, Montreal, PQ, Canada
[2] Univ Montreal, Dept Family Med & Emergency Med, Montreal, PQ, Canada
[3] McGill Univ, Dept Psychiat, Montreal, PQ, Canada
关键词
Injectable opioid agonist treatment; opioid use disorders; professionals; feasibility; acceptability; ASSISTED TREATMENT; COST-EFFECTIVENESS; HEROIN; METHADONE; TRIAL; BUPRENORPHINE; BARRIERS; DRUG;
D O I
10.1080/09687637.2022.2040007
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background Engagement of health care professionals represents an important factor for successful implementation of new practices. To support these professionals' involvement, it is essential to understand their perspective. This study describes the perspective of professionals in the field of opioid use disorder (OUD), in the province of Quebec (Canada), regarding appropriateness of iOAT for their patients and the obstacles to its implementation. Methods A web-based survey was conducted, with 132 OUD professionals (physicians, pharmacists, nurses and counselors). Results 80.3% of respondents report prior knowledge of iOAT, 87.6% are interested in obtaining additional information on iOAT, and 98.1% consider iOAT to be very or partially appropriate for their clientele. In terms of barriers to iOAT implementation, the main obstacles highlighted by respondents pertain to the lack of available or qualified staff, access to appropriate facilities and equipment, and patient transportation. Professionals who perceive iOAT to be very appropriate for their clientele are more likely to report a higher number of patients with biopsychosocial deterioration, to consider themselves to be very familiar with iOAT, and to work in a higher population density area. Conclusions Results highlight feasibility challenges, but support perceived appropriateness of iOAT in a sample of OUD professionals in Quebec.
引用
收藏
页码:434 / 442
页数:9
相关论文
共 50 条
  • [41] Role of Medication in the Treatment of Opioid Use Disorders
    Baird, Carolyn
    [J]. JOURNAL OF ADDICTIONS NURSING, 2015, 26 (04) : 213 - 216
  • [42] Opioid maintenance therapy for the treatment of opioid use disorders in outpatients with or without schizophrenia
    Bouton, J. F.
    Laqueille, X.
    Bourdel, M. C.
    Dervaux, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S1075 - S1076
  • [43] Injectable Opioid use: An insight into the problem
    Anwar, Zeeshan
    Agrawal, Renu
    Sinha, Vishal
    Gurnani, Kishan Chand
    Mitra, Sayantanava
    Mishra, Ashwani Kumar
    [J]. INDIAN JOURNAL OF COMMUNITY HEALTH, 2016, 28 (02) : 185 - 191
  • [44] Opioid Use Disorders
    Sharma, Bikash
    Bruner, Ann
    Barnett, Gabrielle
    Fishman, Marc
    [J]. CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2016, 25 (03) : 473 - +
  • [45] Self-managing illicit stimulant use: A qualitative study with patients receiving injectable opioid agonist treatment
    Palis, Heather
    Harrison, Scott
    MACDonald, Scott
    Marsh, David C.
    Schechter, Martin T.
    Oviedo-Joekes, Eugenia
    [J]. DRUG AND ALCOHOL REVIEW, 2020, 39 (07) : 914 - 923
  • [46] Pharmacological treatment for depression during opioid agonist treatment for opioid dependence
    Pani, Pier Paolo
    Vacca, Rosangela
    Trogu, Emanuela
    Amato, Laura
    Davoli, Marina
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (09):
  • [47] Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a US national sample
    Krawczyk, Noa
    Feder, Kenneth A.
    Fingerhood, Michael I.
    Saloner, Brendan
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2017, 178 : 512 - 518
  • [48] Divergent emotional and autonomic responses to Cyberball in patients with opioid use disorder on opioid agonist treatment
    Gerra, Maria Lidia
    Ossola, Paolo
    Ardizzi, Martina
    Martorana, Silvia
    Leoni, Veronica
    Riva, Paolo
    Preti, Emanuele
    Marchesi, Carlo
    Gallese, Vittorio
    De Panfilis, Chiara
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2023, 231
  • [49] Exploring Patients' Perceptions on Injectable Opioid Agonist Treatment: Influences on Treatment Initiation and Implications for Practice
    Friedmann, Zoe
    Binder, Annette
    Kinkel, Hans-Tilmann
    Kuehner, Claudia
    Zsolnai, Andreas
    Mick, Inge
    [J]. EUROPEAN ADDICTION RESEARCH, 2024, 30 (01) : 32 - 42
  • [50] Reasons for not entering opioid agonist treatment: A survey among high-risk opioid users in Finland
    Prami, Tuire
    Polkki, Mari
    Ruotsalainen, Jarno
    Nordbeck, Elin Banke
    Meyner, Susanna
    Kaski, Ari
    [J]. NORDIC STUDIES ON ALCOHOL AND DRUGS, 2024, 41 (02) : 200 - 211